The Life Improvement Trial (LIFT)

The Life Improvement Trial (LIFT) aims to investigate two drugs, separately and in combination, Pyridostigmine (commonly known as Mestinon) and Low-Dose Naltrexone (LDN), for efficacy and to research the difference between responders and non-responders.
Investigating PEM via Muscle Biopsy in ME/CFS and Long COVID

This study explores the biological changes that occur in the muscles during post-exertional malaise (PEM), both in historical cases of ME/CFS and cases of Long COVID that meet the criteria for ME/CFS.
Sleep Disturbance in ME/CFS and Long COVID
We intend to examine multiple sleep studies that have been conducted in the past two years and performed at the MGH Neurology Sleep Medicine Laboratory in well characterized patients with ME/CFS.
Multi-omics Exercise Intolerance

This project aims to understand the origin of postural orthostatic tachycardia syndrome (POTS).
iCPET Retrospective Study of ME/CFS & Long COVID

This study aims to evaluate different explanations of preload failure in ME/CFS patients.